Andembry 200 mg, Injektionslösung im Fertigpen
7680695530018
CH-69553
Injektionslösung im Fertigpen
Associated product:
ANDEMBRY 200 mg sol inj stylo autoinj
1 / 3
google
Article details
- Package size
- 1
- Selling units
- unbekannt
- Measure
- Fertigpen
- Galenic form
- Injektionslösung im Fertigpen
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
garadacimabum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
arginini hydrochloridum
|
- | Substance | HNIDK |
|
prolinum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 16158.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2025
Authorization holder
CSL Behring AG
3014 Bern
Authorization information
- Swissmedic authorization number
- 69553
- Drug name
- Andembry, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- B06AC07
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 24/02/2025
- Authorization expiration date
- 23/02/2030
- IT Number
- 02.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ANDEMBRY 200 mg sol inj stylo autoinj
- Description (DE)
- ANDEMBRY 200 mg Inj Lsg AI
- Market launch
- 01/07/2025
- Narcotic (BTM)
- No